Clinical Trial: Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Desmopressin as a Therapy for Nocturnal Enuresis in Patients With Sickle Cell Disease

Brief Summary: This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease. Half of the children will receive placebo and half of the children will receive desmopressin, with the option to prescribe desmopressin as soon as the study is completed.